We conclude that our new Cre-inducible models express transgenic APP at levels comparable to other amyloid mouse strains and that amyloid onset in each model is dictated by the combination of expression levels, the presence or absence of mutant presenilin and the specific APP mutations encoded. Here, APP is linked to amyloidosis.